A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise = Quantitative analysis of the genes determining spinal muscular atrophy

Nagymihály, Mariann and Herczegfalvi, Ágnes and Tímár, László and Karcagi, Veronika (2009) A spinalis izomatrophiát meghatározó survival motoneuron gének kvantitatív analízise = Quantitative analysis of the genes determining spinal muscular atrophy. IDEGGYOGYASZATI SZEMLE / CLINICAL NEUROSCIENCE, 62 (7-8). pp. 390-397. ISSN 0019-1442

Preview

Text a_spinalis_izomatrophiat_meghatarozo_survival_motoneuron_genek_kvantitativ_analizise_5052_u.pdf Download (453kB) | Preview

Abstract

Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases, affecting approximately one in 10,000 live births and with a carrier frequency of approximately one in 35. The disease is caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes. Due to a single nucleotide polymorphism in exon 7, SMN2 produces less full-length transcript than SMN1 and cannot prevent neuronal cell death at physiologic gene dosages. On the other hand, the copy number of SMN2 affects the amount of SMN protein produced and the severity of the SMA phenotype. SMN gene dosage analysis can determine the copy number of SMN1 to detect carriers and patients heterozygous for the absence of SMN1 exon 7. This study provides copy number estimation of SMN1 gene by real-time PCR technique in 56 SMA type I., II., III. patients, 159 parents and healthy relatives and in 152 undefined SMA patients. Among the family members, 91 carriers have been detected and in 56 patients homozygous deletion of SMN1 exon 7 has been confirmed. Moreover, in 12 patients compound heterozygosity of SMN1 exon 7 mutation has been detected, thus providing the possible diagnosis of SMA. In 94 patients, copy number of SMN2 has also been evaluated and a good correlation has been found with the phenotype of the disease. Due to the genetic complexity and the high carrier frequency, accurate risk assessment and genetic counselling are particularly important for the families. These new results provide improvement of the diagnostic service in SMA in Hungary with focus on proper genetic counselling and possible enrolment of the patients in future therapeutic interventions.

Actions (login required)

Edit Item